AR018260A1 - A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS - Google Patents
A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESSInfo
- Publication number
- AR018260A1 AR018260A1 ARP980106616A ARP980106616A AR018260A1 AR 018260 A1 AR018260 A1 AR 018260A1 AR P980106616 A ARP980106616 A AR P980106616A AR P980106616 A ARP980106616 A AR P980106616A AR 018260 A1 AR018260 A1 AR 018260A1
- Authority
- AR
- Argentina
- Prior art keywords
- gammaglobulin
- administered intravenously
- dichoprocess
- prepare
- gammaglobulin solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Un proceso para producir una solucion de gammaglobulina que puede ser administrada por vía intravenosa, sustancialmente libre de virus contaminantes,mediante el tratamiento con calor para inactivacion viral y fraccionamiento de una solucion de gammaglobulina impura y luego tratando la gammagloblulinapurificada con un solvente-detergente para inactivacion viral adicional. Solucion de gammaglobulina obtenida por dicho proceso.A process for producing a gamma globulin solution that can be administered intravenously, substantially free of contaminating viruses, by heat treatment for viral inactivation and fractionation of an impure gamma globulin solution and then treating the purified gamma globulin with a solvent-detergent for inactivation. additional viral. Gammaglobulin solution obtained by said process.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99795297A | 1997-12-24 | 1997-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018260A1 true AR018260A1 (en) | 2001-11-14 |
Family
ID=25544595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980106616A AR018260A1 (en) | 1997-12-24 | 1998-12-22 | A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0971727A4 (en) |
JP (1) | JP2001514672A (en) |
KR (1) | KR20000075562A (en) |
CN (1) | CN1214042C (en) |
AR (1) | AR018260A1 (en) |
AU (1) | AU747893B2 (en) |
BR (1) | BR9807598A (en) |
CA (1) | CA2281938A1 (en) |
CO (1) | CO4970799A1 (en) |
IL (1) | IL131471A0 (en) |
MY (1) | MY117328A (en) |
RU (1) | RU2198668C2 (en) |
TW (1) | TW546144B (en) |
UA (1) | UA64742C2 (en) |
WO (1) | WO1999033484A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4685238B2 (en) * | 1998-06-09 | 2011-05-18 | ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト | Process for the production of intravenous immunoglobulins and other immunoglobulin products |
KR20020010921A (en) * | 1999-06-15 | 2002-02-06 | 콜튼 에드워드 에이. | Manufacturing method for intravenous immune globulin and resultant product |
CA2423805A1 (en) * | 2000-09-28 | 2002-04-04 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
ES2184594B1 (en) * | 2001-01-17 | 2004-01-01 | Probitas Pharma Sa | PROCEDURE FOR THE PRODUCTION OF GAMMAGLOBULINA G HUMANA INACTIVADA OF VIRUS. |
US6893639B2 (en) | 2001-10-19 | 2005-05-17 | Hemacare Corporation | Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
CA2497364C (en) | 2002-09-11 | 2013-03-19 | Chugai Seiyaku Kabushiki Kaisha | Protein purification method |
TWI320788B (en) | 2005-05-25 | 2010-02-21 | Hoffmann La Roche | Method for the purification of antibodies |
KR100791502B1 (en) * | 2006-09-29 | 2008-01-03 | 한스바이오메드 주식회사 | Production methods of virus inactivated and cell-free body implant |
WO2010059232A1 (en) * | 2008-11-20 | 2010-05-27 | Biogen Idec Ma Inc. | Arginine inactivation of viruses |
IL212911A0 (en) * | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
ES2381828B1 (en) * | 2012-03-20 | 2012-11-16 | Grifols, S.A. | PROCEDURE TO OBTAIN A COMPOSITION OF IgG THROUGH THERMAL TREATMENT |
KR101917196B1 (en) * | 2014-03-11 | 2018-11-09 | 주식회사 녹십자홀딩스 | Method for purifying immunoglobulin |
CN107880116B (en) * | 2016-09-30 | 2023-02-03 | 盖立复集团公司 | Method for producing immunoglobulins |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2604759C2 (en) * | 1976-02-07 | 1983-06-01 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Method of Obtaining IV Compatible Gamma Globulins |
US4820805A (en) * | 1983-07-14 | 1989-04-11 | New York Blood Center, Inc. | Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives |
US4835257A (en) * | 1984-07-07 | 1989-05-30 | Armour Pharma Gmbh | Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer |
FR2582515B1 (en) * | 1985-05-30 | 1988-11-04 | Merieux Inst | PROCESS FOR THE PREPARATION OF GAMMA-GOBULINS ADMINISTRABLE BY THE INTRAVENOUS ROUTE AND GAMMA-GLOBULINS OBTAINED |
JPH0662436B2 (en) * | 1986-05-19 | 1994-08-17 | 株式会社ミドリ十字 | Method for producing intravenous immunoglobulin preparation |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
DE3825429C2 (en) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Method for producing an intravenously administrable polyclonal immunoglobulin preparation with a high IgM content |
ES2057191T5 (en) * | 1989-01-13 | 2003-05-01 | Mitsubishi Pharma Corp | PRODUCTION METHOD FOR A COMPOSITION CONTAINING PROTEINS. |
JP2965069B2 (en) * | 1989-01-13 | 1999-10-18 | 吉富製薬株式会社 | Method for producing protein-containing composition |
ES2087156T3 (en) * | 1989-06-15 | 1996-07-16 | Rorer Int Overseas | METHODS FOR THE INACTIVATION OF VIRUSES IN PHARMACEUTICAL COMPOSITIONS CONTAMINATED BY VIRUSES. |
US5177194A (en) * | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
JP3145696B2 (en) * | 1990-10-05 | 2001-03-12 | 日本ケミカルリサーチ株式会社 | Method for producing secretory immunoglobulin A preparation |
US5110910A (en) * | 1991-03-25 | 1992-05-05 | Miles Inc. | Virucidal euglobulin precipitation |
DE4431833C1 (en) * | 1994-09-07 | 1995-05-18 | Blutspendedienst Der Drk Lande | Prepn. of an anti-haemophilic factor from a cryo-precipitate |
JP4003235B2 (en) * | 1994-09-30 | 2007-11-07 | 三菱ウェルファーマ株式会社 | Method for producing intravenous immunoglobulin preparation |
-
1998
- 1998-07-12 UA UA99084781A patent/UA64742C2/en unknown
- 1998-12-07 CN CNB988043769A patent/CN1214042C/en not_active Expired - Fee Related
- 1998-12-07 WO PCT/US1998/025208 patent/WO1999033484A1/en not_active Application Discontinuation
- 1998-12-07 KR KR1019997007622A patent/KR20000075562A/en not_active Application Discontinuation
- 1998-12-07 BR BR9807598-5A patent/BR9807598A/en not_active Application Discontinuation
- 1998-12-07 RU RU99120190/14A patent/RU2198668C2/en not_active IP Right Cessation
- 1998-12-07 AU AU17038/99A patent/AU747893B2/en not_active Ceased
- 1998-12-07 CA CA002281938A patent/CA2281938A1/en not_active Abandoned
- 1998-12-07 IL IL13147198A patent/IL131471A0/en unknown
- 1998-12-07 EP EP98961803A patent/EP0971727A4/en not_active Withdrawn
- 1998-12-07 JP JP53498599A patent/JP2001514672A/en not_active Ceased
- 1998-12-22 AR ARP980106616A patent/AR018260A1/en unknown
- 1998-12-23 TW TW087121571A patent/TW546144B/en not_active IP Right Cessation
- 1998-12-23 MY MYPI98005848A patent/MY117328A/en unknown
- 1998-12-23 CO CO98076460A patent/CO4970799A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1214042C (en) | 2005-08-10 |
CN1252729A (en) | 2000-05-10 |
AU747893B2 (en) | 2002-05-30 |
AU1703899A (en) | 1999-07-19 |
KR20000075562A (en) | 2000-12-15 |
EP0971727A4 (en) | 2005-01-19 |
BR9807598A (en) | 2000-02-22 |
UA64742C2 (en) | 2004-03-15 |
JP2001514672A (en) | 2001-09-11 |
IL131471A0 (en) | 2001-01-28 |
EP0971727A1 (en) | 2000-01-19 |
CO4970799A1 (en) | 2000-11-07 |
RU2198668C2 (en) | 2003-02-20 |
WO1999033484A1 (en) | 1999-07-08 |
CA2281938A1 (en) | 1999-07-08 |
MY117328A (en) | 2004-06-30 |
TW546144B (en) | 2003-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR018260A1 (en) | A PROCESS TO PREPARE A GAMMAGLOBULIN SOLUTION THAT CAN BE ADMINISTERED INTRAVENOUSLY, AND GAMMAGLOBULIN SOLUTION OBTAINED BY DICHOPROCESS | |
ES2057191T5 (en) | PRODUCTION METHOD FOR A COMPOSITION CONTAINING PROTEINS. | |
ES2148332T3 (en) | PROCEDURE FOR THE PRODUCTION OF IMMUNOGLOBULIN CONCENTRATE G. | |
CO4960659A1 (en) | VACCINE INCLUDING AN ANTIGEN FOR HEPATITIS B VIRUSES AND AN ANTIGEN FOR HERPES SIMPLEX VIRUS | |
EP1852121A3 (en) | Lipid analogs for treating viral infections | |
ATE298741T1 (en) | POLYAROMATIC COMPOUNDS FOR THE TREATMENT OF HERPES INFECTIONS | |
NO883306L (en) | PHARMASOYYTIC ACTIVE CONJUGATES WITH IMPROVED BODY SPECIFIC BINDING SPECIFICITY. | |
ATE165345T1 (en) | SULFONIC ACID DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES | |
ES2075843T3 (en) | PRODUCTION METHOD OF A CERAMIC SUPERCONDUCTOR WIRE. | |
ES2138603T3 (en) | PROCEDURE FOR THE ISOLATION OF FACTORS IX, X AND II HIGHLY PURIFIED FROM THE PROTO-COMBIN COMPLEX OR THE HUMAN PLASMA. | |
ES2038650T3 (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION INCLUDING 3'-DEOXYTIMIDIN-2'-ENO- (3'-DESOXI-2 ', 3'-DIDESHIDROTIMIDINA) TO TREAT PATIENTS INFECTED WITH RETROVIRUS. | |
BR0010815A (en) | Method of preparing viral doubly inactivated immune globulin for intravenous administration | |
ES2140652T3 (en) | USE OF N-ALKYL-DERIVATIVES OF 1,5-DIDESOXI-1,5-IMINO-D-GLUCITOL FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS. | |
MX9203011A (en) | PROCEDURE FOR PREPARING AN AQUEOUS VON WILLEBRAND FACTOR FRAGMENT SOLUTION ALTERED WITH CYSTEINE AND THERAPEUTIC SOLUTION FUSED THROUGH THE SAME | |
NO931476L (en) | PROCEDURE FOR MANUFACTURING A VIRUS SAFE, HIGHLY FACTOR VIII | |
ES8505820A1 (en) | A process for producing a hepatitis B infection preventing vaccine. | |
ES2113910T3 (en) | PROCEDURE FOR THE PREPARATION OF A TROMBINE CONCENTRATE INSURED AGAINST VIRUSES. | |
NO940810L (en) | Treatment of viral infections | |
ES2053684T3 (en) | PROCEDURE TO PREPARE A HIGHLY PURE, NON-INFECTIOUS ANTIHEMOPHILIC FACTOR THROUGH CHROMATOGRAPHY. | |
ES2118386T3 (en) | PROCEDURE FOR THE INACTIVATION OF VIRUSES THAT ARE NOT PROVIDED WITH LIPID ENVELOPES. | |
EA200100133A1 (en) | OXAZOLIDINONES FOR THE TREATMENT OF INFECTIOUS EYE DISEASES | |
MX9307337A (en) | STEAM HEAT TREATMENT METHOD FOR POLYBENZAZOLE FIBER. | |
BR0011648A (en) | Manufacturing method of intravenous immunoglobulin and resulting product | |
ATE247474T1 (en) | USE OF INOSITE TRIPHOSPHATE FOR PRODUCING MEDICINAL PRODUCTS | |
ES2053606T3 (en) | PREPARATION METHOD OF A HIGH PURITY ALPHA-1-PROTEINASE INHIBITOR. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |